< Back to Article

4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp

Table 5

Impact of fHbp alanine point mutations on binding to mAb 4B3.

doi: https://doi.org/10.1371/journal.ppat.1008882.t005